This inventor holds 3 USPTO granted patents and 7 published patent applications and 3 EPO patents. Top assignee: Zhaoke (Guangzhou) Ophthalmic Drug Company Limited. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Guangzhou, CN (2021)
- Hefei, CN (2021 - 2022)
Company Filing History:
Years Active: 2021-2022
Title: Xiangrong Dai: Innovator in Pharmaceutical Formulations
Introduction
Xiangrong Dai is a notable inventor based in Hefei, China. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of eye care and dermatological products. With a total of 3 patents, his work showcases innovative approaches to drug delivery systems.
Latest Patents
One of his latest patents is a treatment process for cyclosporine eye gel. This process involves several steps, including the preparation of a carbomer base, which is then mixed with cyclosporin A and other components to create a clear solution. The method emphasizes sterilization and filtration before adding carbomer, making it suitable for industrial production. Another significant patent is the dispersion process of adapalene in a gel preparation. This process includes pulverizing adapalene to specific particle sizes and creating a uniform jelly matrix, which enhances the emulsifying and dispersing effects of the active ingredient.
Career Highlights
Xiangrong Dai has worked with reputable companies such as Zhaoke Ophthalmic Drug Company Limited and Zhaoke Pharmaceutical Company Limited. His experience in these organizations has allowed him to refine his skills in pharmaceutical development and innovation.
Collaborations
Throughout his career, Xiangrong has collaborated with professionals like Gang Li and Xiaoyi Li. These partnerships have contributed to the successful development of his patented processes and formulations.
Conclusion
Xiangrong Dai's innovative work in pharmaceutical formulations highlights his expertise and commitment to advancing drug delivery systems. His contributions are poised to make a significant impact in the fields of ophthalmology and dermatology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile